| SLPAX | VSMAX | SLPAX / VSMAX | |
| Total Expense Ratio | 0.42 | 0.05 | 840% |
| Annual Report Gross Expense Ratio | 0.72 | 0.05 | 1,440% |
| Fund Existence | 30 years | 26 years | - |
| Gain YTD | 16.400 | 15.756 | 104% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 3000 | 3,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 202M | 189B | 0% |
| Annual Yield % from dividends | 0.94 | 1.18 | 79% |
| Returns for 1 year | 1.05 | 23.38 | 4% |
| Returns for 3 years | 23.77 | 48.24 | 49% |
| Returns for 5 years | -18.02 | 38.56 | -47% |
| Returns for 10 years | -6.73 | 158.07 | -4% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 38.32 | N/A | N/A |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| SPBW | 28.78 | -0.06 | -0.22% |
| AllianzIM Buffer20 Allocation ETF | |||
| SMIG | 33.12 | -0.09 | -0.27% |
| Bahl & Gaynor Sm/Md Cp Inc Gr ETF | |||
| IJAN | 37.98 | -0.17 | -0.45% |
| Innovator Itnl Dvp Pwr Buff ETF™ Jan | |||
| MBCE | 38.69 | -1.03 | -2.59% |
| Monarch Blue Chips Elite Index ETF | |||